instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Trichiasis'? | Dupilumab Induced Limbal Stem Cell Deficiency.
Dupilumab is a monoclonal antibody that is used for the treatment of atopic dermatitis (AD) in adults. However, increasing reports of ocular complications including conjunctivitis and dry eye disease have been documented. In this report, we describe a case of a patient who... | Recovering | ReactionOutcome | CC BY-NC | 33981166 | 19,374,980 | 2021 |
What was the outcome of reaction 'Vision blurred'? | Dupilumab Induced Limbal Stem Cell Deficiency.
Dupilumab is a monoclonal antibody that is used for the treatment of atopic dermatitis (AD) in adults. However, increasing reports of ocular complications including conjunctivitis and dry eye disease have been documented. In this report, we describe a case of a patient who... | Recovering | ReactionOutcome | CC BY-NC | 33981166 | 19,374,980 | 2021 |
What was the outcome of reaction 'Visual impairment'? | Dupilumab Induced Limbal Stem Cell Deficiency.
Dupilumab is a monoclonal antibody that is used for the treatment of atopic dermatitis (AD) in adults. However, increasing reports of ocular complications including conjunctivitis and dry eye disease have been documented. In this report, we describe a case of a patient who... | Not recovered | ReactionOutcome | CC BY-NC | 33981166 | 19,374,980 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Atypical posterior reversible encephalopathy syndrome in a case of thrombotic thrombocytopenic purpura with Sjogren's syndrome.
Thrombotic thrombocytopenic purpura (TTP) is a rare hematologic disorder characterized by thrombotic microangiopathy. Neurologic symptoms are frequently seen in its presentation and the most c... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 33981376 | 20,315,595 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Atypical posterior reversible encephalopathy syndrome in a case of thrombotic thrombocytopenic purpura with Sjogren's syndrome.
Thrombotic thrombocytopenic purpura (TTP) is a rare hematologic disorder characterized by thrombotic microangiopathy. Neurologic symptoms are frequently seen in its presentation and the most c... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 33981376 | 20,315,595 | 2021-06 |
What was the dosage of drug 'RITUXIMAB'? | Atypical posterior reversible encephalopathy syndrome in a case of thrombotic thrombocytopenic purpura with Sjogren's syndrome.
Thrombotic thrombocytopenic purpura (TTP) is a rare hematologic disorder characterized by thrombotic microangiopathy. Neurologic symptoms are frequently seen in its presentation and the most c... | FOR 4 DOSES | DrugDosageText | CC BY-NC-ND | 33981376 | 20,315,595 | 2021-06 |
What is the weight of the patient? | Bictegravir-Based Antiretroviral Therapy-Associated Accelerated Hyperglycemia and Diabetes Mellitus.
Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) is first line for treatment of people with human immunodeficiency virus (PWH). Emerging data suggest the possibility of adverse metabolic ef... | 54.4 kg. | Weight | CC BY-NC-ND | 33981777 | 19,301,023 | 2021-05 |
What was the administration route of drug 'PALIPERIDONE PALMITATE'? | Bictegravir-Based Antiretroviral Therapy-Associated Accelerated Hyperglycemia and Diabetes Mellitus.
Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) is first line for treatment of people with human immunodeficiency virus (PWH). Emerging data suggest the possibility of adverse metabolic ef... | Intramuscular | DrugAdministrationRoute | CC BY-NC-ND | 33981777 | 19,301,023 | 2021-05 |
What was the outcome of reaction 'Diabetic ketoacidosis'? | Bictegravir-Based Antiretroviral Therapy-Associated Accelerated Hyperglycemia and Diabetes Mellitus.
Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) is first line for treatment of people with human immunodeficiency virus (PWH). Emerging data suggest the possibility of adverse metabolic ef... | Recovered | ReactionOutcome | CC BY-NC-ND | 33981777 | 19,301,037 | 2021-05 |
What was the outcome of reaction 'Hyperglycaemia'? | Bictegravir-Based Antiretroviral Therapy-Associated Accelerated Hyperglycemia and Diabetes Mellitus.
Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) is first line for treatment of people with human immunodeficiency virus (PWH). Emerging data suggest the possibility of adverse metabolic ef... | Recovered | ReactionOutcome | CC BY-NC-ND | 33981777 | 19,301,037 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaesthesia'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arrhythmia'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood calcium decreased'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood pressure increased'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bloody discharge'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Breast cancer recurrent'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphoria'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Facial discomfort'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoaesthesia'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypocalcaemia'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypozincaemia'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Injection site erythema'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Injection site pain'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Injection site swelling'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lower limb fracture'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumothorax'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Radius fracture'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Serum procollagen type I N-terminal propeptide increased'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Spinal fracture'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tartrate-resistant acid phosphatase decreased'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tibia fracture'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Upper limb fracture'. | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | DENOSUMAB, ROMOSOZUMAB-AQQG | DrugsGivenReaction | CC BY | 33981812 | 19,177,883 | 2021-06 |
What was the administration route of drug 'ROMOSOZUMAB-AQQG'? | Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. Th... | Subcutaneous | DrugAdministrationRoute | CC BY | 33981812 | 19,177,883 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection reactivation'. | Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.
Cytomegalovirus (CMV) reactivation during chemotherapy or after organ or hematopoietic stem cell transplantation is a major cause of morbidity and mortality, and the risk of reactivation increases... | ACYCLOVIR, BENDAMUSTINE, HUMAN IMMUNOGLOBULIN G, RITUXIMAB, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALGANCICLOVIR | DrugsGivenReaction | CC BY | 33981851 | 19,713,731 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.
Cytomegalovirus (CMV) reactivation during chemotherapy or after organ or hematopoietic stem cell transplantation is a major cause of morbidity and mortality, and the risk of reactivation increases... | ACYCLOVIR, BENDAMUSTINE, HUMAN IMMUNOGLOBULIN G, RITUXIMAB, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALGANCICLOVIR | DrugsGivenReaction | CC BY | 33981851 | 19,713,731 | 2021 |
What was the dosage of drug 'VALGANCICLOVIR'? | Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.
Cytomegalovirus (CMV) reactivation during chemotherapy or after organ or hematopoietic stem cell transplantation is a major cause of morbidity and mortality, and the risk of reactivation increases... | 900 MG, DAILY | DrugDosageText | CC BY | 33981851 | 19,713,731 | 2021 |
What was the outcome of reaction 'Cytomegalovirus infection reactivation'? | Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.
Cytomegalovirus (CMV) reactivation during chemotherapy or after organ or hematopoietic stem cell transplantation is a major cause of morbidity and mortality, and the risk of reactivation increases... | Fatal | ReactionOutcome | CC BY | 33981851 | 19,713,731 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gait inability'. | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | FILGRASTIM, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33981866 | 19,481,526 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intraductal proliferative breast lesion'. | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | FILGRASTIM, MITOMYCIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33981866 | 19,454,848 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Papillary thyroid cancer'. | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | FILGRASTIM, MITOMYCIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33981866 | 19,454,848 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Radiation skin injury'. | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | FILGRASTIM, MITOMYCIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33981866 | 19,454,848 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vulvar dysplasia'. | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | FILGRASTIM, MITOMYCIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33981866 | 19,454,848 | 2021-05 |
What was the dosage of drug 'PACLITAXEL'? | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | 12 WEEKS | DrugDosageText | CC BY-NC-ND | 33981866 | 19,481,526 | 2021-05 |
What was the outcome of reaction 'Gait inability'? | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | Recovering | ReactionOutcome | CC BY-NC-ND | 33981866 | 19,481,526 | 2021-05 |
What was the outcome of reaction 'Intraductal proliferative breast lesion'? | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | Recovered | ReactionOutcome | CC BY-NC-ND | 33981866 | 19,454,848 | 2021-05 |
What was the outcome of reaction 'Neuropathy peripheral'? | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | Recovering | ReactionOutcome | CC BY-NC-ND | 33981866 | 19,481,526 | 2021-05 |
What was the outcome of reaction 'Papillary thyroid cancer'? | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | Recovered | ReactionOutcome | CC BY-NC-ND | 33981866 | 19,454,848 | 2021-05 |
What was the outcome of reaction 'Radiation skin injury'? | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | Recovered | ReactionOutcome | CC BY-NC-ND | 33981866 | 19,454,848 | 2021-05 |
What was the outcome of reaction 'Vulvar dysplasia'? | Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancer... | Recovered | ReactionOutcome | CC BY-NC-ND | 33981866 | 19,454,848 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | ENOXAPARIN, IBUPROFEN, PHENPROCOUMON | DrugsGivenReaction | CC BY | 33981918 | 19,238,750 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematoma muscle'. | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | ENOXAPARIN, IBUPROFEN, PHENPROCOUMON | DrugsGivenReaction | CC BY | 33981918 | 19,238,750 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematoma'. | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | ENOXAPARIN, IBUPROFEN | DrugsGivenReaction | CC BY | 33981918 | 19,314,053 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle haemorrhage'. | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | ENOXAPARIN, IBUPROFEN, PHENPROCOUMON | DrugsGivenReaction | CC BY | 33981918 | 19,238,750 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | ENOXAPARIN, IBUPROFEN, PHENPROCOUMON | DrugsGivenReaction | CC BY | 33981918 | 19,238,750 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain in extremity'. | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | ENOXAPARIN, IBUPROFEN, PHENPROCOUMON | DrugsGivenReaction | CC BY | 33981918 | 19,238,750 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Platelet function test abnormal'. | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | ENOXAPARIN, IBUPROFEN, PHENPROCOUMON | DrugsGivenReaction | CC BY | 33981918 | 19,238,750 | 2021 |
What was the administration route of drug 'ENOXAPARIN'? | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | Subcutaneous | DrugAdministrationRoute | CC BY | 33981918 | 19,238,750 | 2021 |
What was the administration route of drug 'IBUPROFEN'? | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | Oral | DrugAdministrationRoute | CC BY | 33981918 | 19,238,750 | 2021 |
What was the administration route of drug 'PHENPROCOUMON'? | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | Oral | DrugAdministrationRoute | CC BY | 33981918 | 19,238,750 | 2021 |
What was the outcome of reaction 'Haematoma'? | Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.
Needle electromyography (EMG) is an essential part of electrodiagnosis (EDX) in neuromuscular disorders. As in all invasive procedures there is a risk of bleeding complications, but which is rare according to th... | Recovered | ReactionOutcome | CC BY | 33981918 | 19,314,053 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epilepsy'. | Methylphenidate treatment for cognitive symptoms associated with ADHD in a pediatric epilepsy patient following resection of a left frontal cortical dysplasia.
We present data on a 10-year-old patient with drug-resistant epilepsy who was treated with methylphenidate for symptoms of attention deficit hyperactivity disor... | LAMOTRIGINE, OXCARBAZEPINE, PHENYTOIN | DrugsGivenReaction | CC BY | 33981985 | 20,041,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Complexities of pyridoxine response in PNPO deficiency.
Pyridox(am)ine- 5- phosphate Oxidase deficiency (PNPO) is a rare cause of neonatal metabolic encephalopathy associated with refractory status epilepticus. We report a case of a premature neonate presenting with drug-resistant seizures beginning at 2 hours of life.... | BIOTIN, CLOBAZAM, LEUCOVORIN, LEVETIRACETAM, PHENOBARBITAL, PYRIDOXINE, TOPIRAMATE | DrugsGivenReaction | CC BY-NC-ND | 33981986 | 20,732,023 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Complexities of pyridoxine response in PNPO deficiency.
Pyridox(am)ine- 5- phosphate Oxidase deficiency (PNPO) is a rare cause of neonatal metabolic encephalopathy associated with refractory status epilepticus. We report a case of a premature neonate presenting with drug-resistant seizures beginning at 2 hours of life.... | BIOTIN, CLOBAZAM, LEUCOVORIN, LEVETIRACETAM, PHENOBARBITAL, PYRIDOXINE, TOPIRAMATE | DrugsGivenReaction | CC BY-NC-ND | 33981986 | 20,732,023 | 2021 |
What is the weight of the patient? | Complexities of pyridoxine response in PNPO deficiency.
Pyridox(am)ine- 5- phosphate Oxidase deficiency (PNPO) is a rare cause of neonatal metabolic encephalopathy associated with refractory status epilepticus. We report a case of a premature neonate presenting with drug-resistant seizures beginning at 2 hours of life.... | 1.5 kg. | Weight | CC BY-NC-ND | 33981986 | 20,732,023 | 2021 |
What was the administration route of drug 'PYRIDOXINE'? | Complexities of pyridoxine response in PNPO deficiency.
Pyridox(am)ine- 5- phosphate Oxidase deficiency (PNPO) is a rare cause of neonatal metabolic encephalopathy associated with refractory status epilepticus. We report a case of a premature neonate presenting with drug-resistant seizures beginning at 2 hours of life.... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33981986 | 20,732,023 | 2021 |
What was the dosage of drug 'BIOTIN'? | Complexities of pyridoxine response in PNPO deficiency.
Pyridox(am)ine- 5- phosphate Oxidase deficiency (PNPO) is a rare cause of neonatal metabolic encephalopathy associated with refractory status epilepticus. We report a case of a premature neonate presenting with drug-resistant seizures beginning at 2 hours of life.... | 10 MG, QD | DrugDosageText | CC BY-NC-ND | 33981986 | 20,732,023 | 2021 |
What was the dosage of drug 'LEUCOVORIN'? | Complexities of pyridoxine response in PNPO deficiency.
Pyridox(am)ine- 5- phosphate Oxidase deficiency (PNPO) is a rare cause of neonatal metabolic encephalopathy associated with refractory status epilepticus. We report a case of a premature neonate presenting with drug-resistant seizures beginning at 2 hours of life.... | 3 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY-NC-ND | 33981986 | 20,732,023 | 2021 |
What was the dosage of drug 'PYRIDOXINE'? | Complexities of pyridoxine response in PNPO deficiency.
Pyridox(am)ine- 5- phosphate Oxidase deficiency (PNPO) is a rare cause of neonatal metabolic encephalopathy associated with refractory status epilepticus. We report a case of a premature neonate presenting with drug-resistant seizures beginning at 2 hours of life.... | 100 MG, UNK | DrugDosageText | CC BY-NC-ND | 33981986 | 20,732,023 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features.
Middle ear adenomas with neuroendocrine features (ANEF) are rare, with an estimated 150 reported cases. They usually pursue an indolent clinical course. Four reported cases of middle ear ANEF with distant metas... | CARBOPLATIN, ETOPOSIDE, LUTETIUM OXODOTREOTIDE LU-177 | DrugsGivenReaction | CC BY-NC-ND | 33982661 | 19,477,808 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features.
Middle ear adenomas with neuroendocrine features (ANEF) are rare, with an estimated 150 reported cases. They usually pursue an indolent clinical course. Four reported cases of middle ear ANEF with distant metas... | CARBOPLATIN, ETOPOSIDE, LUTETIUM OXODOTREOTIDE LU-177 | DrugsGivenReaction | CC BY-NC-ND | 33982661 | 19,477,808 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features.
Middle ear adenomas with neuroendocrine features (ANEF) are rare, with an estimated 150 reported cases. They usually pursue an indolent clinical course. Four reported cases of middle ear ANEF with distant metas... | CARBOPLATIN, ETOPOSIDE, OCTREOTIDE | DrugsGivenReaction | CC BY-NC-ND | 33982661 | 19,866,401 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features.
Middle ear adenomas with neuroendocrine features (ANEF) are rare, with an estimated 150 reported cases. They usually pursue an indolent clinical course. Four reported cases of middle ear ANEF with distant metas... | CARBOPLATIN, ETOPOSIDE, OCTREOTIDE ACETATE | DrugsGivenReaction | CC BY-NC-ND | 33982661 | 19,359,481 | 2021-05-01 |
What was the outcome of reaction 'Neoplasm progression'? | Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features.
Middle ear adenomas with neuroendocrine features (ANEF) are rare, with an estimated 150 reported cases. They usually pursue an indolent clinical course. Four reported cases of middle ear ANEF with distant metas... | Fatal | ReactionOutcome | CC BY-NC-ND | 33982661 | 19,866,401 | 2021-05-01 |
What was the outcome of reaction 'Pancytopenia'? | Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features.
Middle ear adenomas with neuroendocrine features (ANEF) are rare, with an estimated 150 reported cases. They usually pursue an indolent clinical course. Four reported cases of middle ear ANEF with distant metas... | Fatal | ReactionOutcome | CC BY-NC-ND | 33982661 | 19,866,401 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erosive oesophagitis'. | Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial.
OBJECTIVE
We evaluated whether ivermectin combined with doxycycline reduced the clinical recovery time in adults with COVID-19 infection.
METHODS
This was a randomized, blinded, placebo-controlled trial in patients with mil... | DOXYCYCLINE, IVERMECTIN | DrugsGivenReaction | CC BY-NC | 33983065 | 19,423,617 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | ACYCLOVIR, MYCOPHENOLIC ACID, PREDNISONE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33985363 | 18,695,217 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus viraemia'. | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | ACYCLOVIR, MYCOPHENOLIC ACID, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33985363 | 18,669,549 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disseminated cytomegaloviral infection'. | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | ACYCLOVIR, MYCOPHENOLIC ACID, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33985363 | 19,358,953 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalitis cytomegalovirus'. | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | ACYCLOVIR, MYCOPHENOLIC ACID, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33985363 | 18,669,549 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic necrosis'. | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | ACYCLOVIR, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33985363 | 18,702,146 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental status changes'. | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | ACYCLOVIR, MYCOPHENOLIC ACID, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33985363 | 19,358,953 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | ACYCLOVIR, MYCOPHENOLIC ACID, PREDNISONE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33985363 | 18,695,217 | 2021 |
What was the administration route of drug 'GANCICLOVIR'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33985363 | 18,674,320 | 2021 |
What was the dosage of drug 'GANCICLOVIR'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | UNKNOWN | DrugDosageText | CC BY-NC | 33985363 | 18,674,320 | 2021 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | UNKNOWN | DrugDosageText | CC BY-NC | 33985363 | 18,674,320 | 2021 |
What was the dosage of drug 'MYCOPHENOLIC ACID'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 33985363 | 18,669,549 | 2021 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | UNKNOWN | DrugDosageText | CC BY-NC | 33985363 | 18,674,320 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | Not recovered | ReactionOutcome | CC BY-NC | 33985363 | 18,695,217 | 2021 |
What was the outcome of reaction 'Cytomegalovirus infection'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | Recovered | ReactionOutcome | CC BY-NC | 33985363 | 18,695,217 | 2021 |
What was the outcome of reaction 'Cytomegalovirus viraemia'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | Recovered | ReactionOutcome | CC BY-NC | 33985363 | 18,669,549 | 2021 |
What was the outcome of reaction 'Disseminated cytomegaloviral infection'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | Recovered | ReactionOutcome | CC BY-NC | 33985363 | 19,358,953 | 2021 |
What was the outcome of reaction 'Encephalitis cytomegalovirus'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | Recovered | ReactionOutcome | CC BY-NC | 33985363 | 18,669,549 | 2021 |
What was the outcome of reaction 'Renal impairment'? | Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation.
Solid organ transplant recipients are at risk for a wide range of opportunistic infections, the most common being cytomegalovirus. These infections may occur as reactivation of latent disease, donor-derived, or de novo. In this article, we... | Not recovered | ReactionOutcome | CC BY-NC | 33985363 | 18,695,217 | 2021 |
What was the administration route of drug 'AMIKACIN'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | Intravenous drip | DrugAdministrationRoute | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.